Abstract
Double-blind comparison between mesalamine (salofalk) and a preparation of viable E. coli nissle 1917 (mutaflor) for maintenance therapy of ulcerative colitis: [formula omitted]. University of Cologne, E. Schütz, Fachpraxis, Regensburg, M. Stolte, Pathologisches Institut, Bayreuth, Germany, B. Fixa, Hradec Kralove, P. Fric, Praha, Charles University, Czech Republic, G. Judmaier, University Innsbruck, Austria
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
